Author

W. Fong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Approach:statistical model· 2 Organism:virus· 2 Assay:whole-genome sequencing· 2 Approach:benchmark study· 1 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

V. Sintchenko· 5 shared A. Arnott· 3 shared C. Lam· 3 shared J. Kok· 3 shared K. Basile· 3 shared R. J. Rockett· 3 shared D. E. Dwyer· 2 shared D. Ko· 2 shared

Activity by Year

2021-2023 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

V. Sintchenko

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Genomic evolution of SARS-CoV-2 variants of concern under in vitro neutralising selection pressure following two doses of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine

K. Basile, J. E. Agius, W. Fong, K. McPhie, M. Fennel, D. Ko, L. Hueston, C. Lam, A. Arnott, S. C.-A. Chen, S. Maddocks, M. V. N. O Sullivan, D. Dwyer, V. Sintchenko, J. Kok, , CIDMLS COVID-19 Study Group

This study assesses the neutralizing antibody titres against SARS-CoV-2 variants Delta and Beta post-Pfizer-BioNTech vaccination, finding significant reductions compared to wild-type virus.

bioRxiv · Sep 24, 2023 · PreprintMicrobiology

Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting

K. Basile, R. J. Rockett, K. McPhie, M. Fennell, J. Johnson-Mackinnon, J. Agius, W. Fong, H. Rahman, D. Ko, L. Donavan, L. Hueston, C. Lam, A. Arnott, S. Chen, S. Maddocks, , J. Kok

This study shows that Pfizer-BioNTech vaccine boosting increases neutralizing antibodies against Omicron, but they are still lower than against the A.2.2 lineage.

bioRxiv · Dec 12, 2021 · PreprintMicrobiology

SARS-CoV-2 Genome Sequencing Methods Differ In Their Ability To Detect Variants From Low Viral Load Samples

C. Lam, K.-A. Gray, M. Gall, R. Sadsad, A. Arnott, J. Johnson-Mackinnon, W. Fong, K. Basile, J. Kok, D. E. Dwyer, V. Sintchenko, R. J. Rockett

This study compares three SARS-CoV-2 sequencing methods for their ability to detect variants from low viral load samples, finding that ARTIC v3 is most sensitive.

bioRxiv · May 1, 2021Microbiology

Genomic evaluation of Bordetella spp. originating from Australia

W. Fong, V. Timms, E. Sim, V. Sintchenko

This study evaluates genomic changes in Bordetella spp. from Australia using long-read sequencing to close genomes and assess their relationship with global isolates.

bioRxiv · Mar 2, 2021 · PreprintMicrobiology

Comparison of library preparation and sequencing depths for direct sequencing of Bordetella pertussis positive samples

W. Fong, K. Pey, R. Rockett, R. Sadsad, V. Sintchenko, V. Timms

This study evaluates WGS library preparation methods for direct sequencing of B. pertussis clinical samples, finding that the Illumina DNA prep kit with deep sequencing detects vaccine antigen variations and macrolide resistance.

bioRxiv · Feb 14, 2021 · PreprintMicrobiology